An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies
Incyte Corporation
Incyte Corporation
Actym Therapeutics, Inc.
Telix Pharmaceuticals (Innovations) Pty Limited
Eli Lilly and Company
Elevation Oncology
ABM Therapeutics Corporation
Hoffmann-La Roche
Fore Biotherapeutics
BIND Therapeutics